Article Details
Retrieved on: 2023-10-25 16:10:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Data from the first three participants enrolled in the study showed the CRISPR-based treatment to be safe, Excision said. Published Oct. 25, 2023.
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here